AKBA - Akebia Therapeutics Inc Revenue Breakdown

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: KNSA BHC PRGO ALKS AMRX INDV LNTH TEVA VTRS TLX

| Held by: IWM VTI IWO VXF FESM SCHA VTWO IWC SMLF VHT

Scroll to Statements

Index	RUT
Market Cap	375.56M
Enterprise Value	429.13M
Income	-20.51M
Sales	232.40M
Book/sh	0.10
Cash/sh	0.61
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	194
IPO	Mar 20, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	1.62
P/B	13.70
P/C	2.29
P/FCF	6.26
EV/EBITDA	65.32
EV/Sales	1.85
Quick Ratio	1.33
Current Ratio	1.40
Debt/Eq	7.96
LT Debt/Eq	5.77
Option/Short	Yes / Yes

EPS (ttm)	-0.08
EPS next Y	-0.26
EPS next Q	-0.04
EPS this Y	-620.00%
EPS next Y	-83.33%
EPS next 5Y	-
EPS past 3/5Y	65.70% 62.40%
Sales past 3/5Y	-6.88% -4.37%
EPS Y/Y TTM	64.06%
Sales Y/Y TTM	25.69%
EPS Q/Q	-233.99%
Sales Q/Q	-6.61%
Earnings	May 07 BMO
EPS/Sales Surpr.	-7.14% 3.63%

Insider Own	2.80%
Insider Trans	-7.79%
Inst Own	39.62%
Inst Trans	-6.75%
ROA	-6.10%
ROE	-78.96%
ROIC	-11.06%
Gross Margin	80.46%
Oper. Margin	2.28%
Profit Margin	-8.83%
SMA20	22.40%
SMA50	24.68%
SMA200	-11.81%
Trades

Shs Outstand	267.90M
Shs Float	260.76M
Short Float	7.35%
Short Ratio	3.84
Short Interest	19.18M
52W High	4.08 -65.68%
52W Low	0.82 70.17%
Volatility	7.18% 8.30%
ATR (14)	0.09
RSI (14)	71.92
Beta	0.26
Rel Volume	0.83
Avg Volume	5.00M
Volume	4,149,070

Perf Week	12.90%
Perf Month	52.17%
Perf Quarter	-0.71%
Perf Half Y	-8.50%
Perf YTD	-13.04%
Perf Year	-64.82%
Perf 3Y	15.70%
Perf 5Y	-58.94%
Perf 10Y	-84.09%
Recom	1.00
Target Price	4.20
Prev Close	1.43
Price	1.40
Change	-2.10%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)